Uma M Mohanasundaram, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohanasundaram’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88283 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · Annamalai University, Rajah Muthiah Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$1,507
Medicare paid this office $1,507 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 71 · Health risk score 3.47. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75%.
The office billed $5,538, Medicare allowed $2,017 and paid $1,507; for 19 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 19 | 71 | 3.47 | $5,538 | $1,507 |
| 2022 | 11 | 15 | 70 | 4.52 | $2,982 | $1,014 |
| 2021 | 15 | 22 | 67 | 2.88 | $4,591 | $1,485 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$1,078,316
Pharmacies billed $1,078,316 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
835 generic and 622 brand-name prescriptions · $1,078,316 in drug cost · 116 antibiotic prescriptions to 61 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Esbriet | 30 | $342,206 | $11,407 |
| Ofev | 13 | $163,769 | $12,598 |
| Trelegy Ellipta | 119 | $119,899 | $1,008 |
| Dupixent | 32 | $117,075 | $3,659 |
| Prevymis | 11 | $87,537 | $7,958 |
See all 33 drugs
| Esbriet | 30 | $342,206 | $11,407 |
| Ofev | 13 | $163,769 | $12,598 |
| Trelegy Ellipta | 119 | $119,899 | $1,008 |
| Dupixent | 32 | $117,075 | $3,659 |
| Prevymis | 11 | $87,537 | $7,958 |
| Spiriva Respimat | 70 | $58,893 | $841 |
| Stiolto Respimat | 46 | $41,303 | $898 |
| Breyna | 160 | $25,804 | $161 |
| Pirfenidone | 61 | $15,908 | $261 |
| Advair Hfa | 31 | $14,882 | $480 |
| Alvesco | 110 | $11,389 | $104 |
| Symbicort | 22 | $8,106 | $368 |
| Azelastine-Fluticasone | 61 | $7,366 | $121 |
| Combivent Respimat | 13 | $6,888 | $530 |
| Wixela Inhub | 33 | $6,586 | $200 |
| Mycophenolate Mofetil | 19 | $2,102 | $111 |
| Posaconazole | 12 | $1,805 | $150 |
| Albuterol Sulfate Hfa | 71 | $1,254 | $18 |
| Rifampin | 15 | $1,209 | $81 |
| Azithromycin | 57 | $1,188 | $21 |
| Ethambutol | 14 | $1,174 | $84 |
| Mycophenolic Acid | 11 | $1,169 | $106 |
| Zafirlukast | 12 | $969 | $81 |
| Prednisone | 57 | $680 | $12 |
| Montelukast | 69 | $599 | $9 |
| Fluticasone Propionate | 15 | $410 | $27 |
| Gabapentin | 35 | $298 | $9 |
| Pantoprazole | 26 | $233 | $9 |
| Furosemide | 20 | $225 | $11 |
| Doxycycline Monohydrate | 17 | $208 | $12 |
| Azelastine | 12 | $203 | $17 |
| Tadalafil | 12 | $202 | $17 |
| Amoxicillin | 17 | $200 | $12 |
Year by year
| 2024 | 1,457 | 236 | None | 43% | $1,078,316 |
| 2023 | 1,330 | 225 | None | 53% | $1,021,983 |
| 2022 | 1,233 | 210 | 0% (0) | 61% | $1,187,826 |
| 2021 | 1,239 | 203 | 0% (0) | 56% | $1,372,631 |
| 2020 | 1,249 | 215 | 0% (0) | 55% | $873,652 |
| 2019 | 845 | 185 | None | 55% | $604,053 |
| 2018 | 712 | 157 | 0% (0) | 58% | $435,173 |
| 2017 | 955 | 196 | None | 55% | $734,658 |
| 2016 | 990 | 177 | None | 50% | $367,128 |
| 2015 | 939 | 171 | None | 51% | $385,130 |
| 2014 | 1,161 | 198 | 0% (0) | 52% | $357,472 |
| 2013 | 781 | 138 | 0% (0) | 61% | $144,489 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Ofev | 22 | $262,685 | $11,940 |
| Esbriet | 23 | $262,358 | $11,407 |
| Trelegy Ellipta | 106 | $114,165 | $1,077 |
| Spiriva Respimat | 78 | $58,669 | $752 |
| Symbicort | 146 | $49,730 | $341 |
| Pirfenidone | 76 | $33,507 | $441 |
| Stiolto Respimat | 35 | $31,252 | $893 |
| Advair Hfa | 50 | $20,805 | $416 |
| Alvesco | 120 | $12,352 | $103 |
| Wixela Inhub | 21 | $3,068 | $146 |
| Mycophenolate Mofetil | 27 | $2,941 | $109 |
| Azelastine-Fluticasone | 13 | $1,840 | $142 |
| Ethambutol | 16 | $1,417 | $89 |
| Azithromycin | 56 | $1,347 | $24 |
| Rifampin | 14 | $1,341 | $96 |
| Albuterol Sulfate Hfa | 61 | $1,147 | $19 |
| Zafirlukast | 15 | $940 | $63 |
| Prednisone | 50 | $615 | $12 |
| Montelukast | 54 | $449 | $8 |
| Azelastine | 25 | $422 | $17 |
| Fluticasone Propionate | 22 | $409 | $19 |
| Amoxicillin | 22 | $245 | $11 |
| Pantoprazole | 20 | $208 | $10 |
| Furosemide | 17 | $187 | $11 |
| Doxycycline Monohydrate | 13 | $153 | $12 |
| Metoprolol | 12 | $127 | $11 |
| Gabapentin | 14 | $112 | $8 |
2022: 23 drugs
| Esbriet | 40 | $429,227 | $10,731 |
| Ofev | 31 | $354,702 | $11,442 |
| Trelegy Ellipta | 85 | $81,630 | $960 |
| Spiriva Respimat | 112 | $74,268 | $663 |
| Pirfenidone | 38 | $50,168 | $1,320 |
| Advair Hfa | 102 | $44,586 | $437 |
| Symbicort | 126 | $38,327 | $304 |
| Alvesco | 95 | $7,993 | $84 |
| Atovaquone | 17 | $4,302 | $253 |
| Wixela Inhub | 21 | $3,928 | $187 |
| Mycophenolate Mofetil | 22 | $3,309 | $150 |
| Zafirlukast | 15 | $1,543 | $103 |
| Albuterol Sulfate Hfa | 78 | $1,538 | $20 |
| Voriconazole | 14 | $1,175 | $84 |
| Ethambutol | 11 | $825 | $75 |
| Prednisone | 45 | $780 | $17 |
| Montelukast | 83 | $644 | $8 |
| Azelastine | 30 | $508 | $17 |
| Fluticasone Propionate | 26 | $487 | $19 |
| Azithromycin | 22 | $474 | $22 |
| Nystatin | 12 | $281 | $23 |
| Pantoprazole | 20 | $237 | $12 |
| Losartan | 11 | $92 | $8 |
2021: 24 drugs
| Esbriet | 64 | $672,180 | $10,503 |
| Ofev | 32 | $354,761 | $11,086 |
| Advair Hfa | 199 | $99,446 | $500 |
| Spiriva Respimat | 112 | $65,353 | $584 |
| Dulera | 15 | $9,981 | $665 |
| Alvesco | 98 | $7,379 | $75 |
| Wixela Inhub | 35 | $7,070 | $202 |
| Asmanex Hfa | 13 | $4,090 | $315 |
| Mycophenolate Mofetil | 26 | $4,044 | $156 |
| Rifampin | 15 | $1,946 | $130 |
| Zafirlukast | 15 | $1,814 | $121 |
| Albuterol Sulfate Hfa | 67 | $1,586 | $24 |
| Ethambutol | 14 | $1,277 | $91 |
| Azelastine | 56 | $1,259 | $22 |
| Azithromycin | 31 | $1,077 | $35 |
| Montelukast | 127 | $992 | $8 |
| Ventolin Hfa | 14 | $879 | $63 |
| Prednisone | 50 | $807 | $16 |
| Tadalafil | 12 | $760 | $63 |
| Fluticasone Propionate | 24 | $407 | $17 |
| Nystatin | 16 | $317 | $20 |
| Pantoprazole | 14 | $214 | $15 |
| Furosemide | 14 | $163 | $12 |
| Losartan | 12 | $103 | $9 |
2020: 20 drugs
| Esbriet | 48 | $466,674 | $9,722 |
| Ofev | 14 | $150,566 | $10,755 |
| Advair Hfa | 220 | $111,885 | $509 |
| Spiriva Respimat | 141 | $49,270 | $349 |
| Dulera | 25 | $18,730 | $749 |
| Advair Diskus | 54 | $13,603 | $252 |
| Alvesco | 70 | $5,036 | $72 |
| Mycophenolate Mofetil | 26 | $4,522 | $174 |
| Ventolin Hfa | 52 | $2,937 | $56 |
| Azelastine | 73 | $1,473 | $20 |
| Tadalafil | 12 | $1,452 | $121 |
| Montelukast | 153 | $1,169 | $8 |
| Voriconazole | 11 | $1,119 | $102 |
| Prednisone | 54 | $947 | $18 |
| Azithromycin | 33 | $770 | $23 |
| Fluticasone Propionate | 34 | $517 | $15 |
| Ipratropium | 11 | $496 | $45 |
| Sulfamethoxazole-Trimethoprim | 14 | $125 | $9 |
| Levofloxacin | 14 | $121 | $9 |
| Losartan | 11 | $94 | $9 |
2019: 18 drugs
| Esbriet | 37 | $361,061 | $9,758 |
| Advair Hfa | 154 | $92,244 | $599 |
| Spiriva Respimat | 116 | $33,247 | $287 |
| Dulera | 22 | $20,808 | $946 |
| Mycophenolate Mofetil | 39 | $7,229 | $185 |
| Advair Diskus | 24 | $6,673 | $278 |
| Alvesco | 30 | $2,246 | $75 |
| Ventolin Hfa | 26 | $1,765 | $68 |
| Rifampin | 12 | $1,282 | $107 |
| Azithromycin | 51 | $1,086 | $21 |
| Prednisone | 49 | $835 | $17 |
| Montelukast | 50 | $430 | $9 |
| Azelastine | 13 | $304 | $23 |
| Fluticasone Propionate | 17 | $250 | $15 |
| Furosemide | 19 | $220 | $12 |
| Gabapentin | 12 | $200 | $17 |
| Losartan | 16 | $140 | $9 |
| Levofloxacin | 14 | $131 | $9 |
2018: 15 drugs
| Esbriet | 17 | $168,147 | $9,891 |
| Advair Hfa | 97 | $52,706 | $543 |
| Spiriva Respimat | 92 | $25,884 | $281 |
| Mycophenolate Mofetil | 33 | $15,025 | $455 |
| Dulera | 23 | $14,600 | $635 |
| Advair Diskus | 42 | $12,301 | $293 |
| Ventolin Hfa | 37 | $2,400 | $65 |
| Qvar | 25 | $2,222 | $89 |
| Azithromycin | 46 | $1,188 | $26 |
| Prednisone | 47 | $868 | $18 |
| Sildenafil | 13 | $631 | $49 |
| Montelukast | 33 | $421 | $13 |
| Furosemide | 23 | $274 | $12 |
| Levofloxacin | 16 | $155 | $10 |
| Losartan | 11 | $103 | $9 |
2017: 18 drugs
| Esbriet | 46 | $400,006 | $8,696 |
| Letairis | 15 | $138,726 | $9,248 |
| Spiriva Respimat | 147 | $39,119 | $266 |
| Dulera | 154 | $35,242 | $229 |
| Mycophenolate Mofetil | 47 | $30,219 | $643 |
| Advair Diskus | 13 | $9,118 | $701 |
| Qvar | 40 | $3,578 | $89 |
| Ethambutol | 19 | $2,512 | $132 |
| Ventolin Hfa | 43 | $2,031 | $47 |
| Rifampin | 16 | $1,767 | $110 |
| Azithromycin | 61 | $1,564 | $26 |
| Prednisone | 53 | $1,357 | $26 |
| Montelukast | 41 | $639 | $16 |
| Fluticasone Propionate | 22 | $432 | $20 |
| Sulfamethoxazole-Trimethoprim | 27 | $418 | $15 |
| Ipratropium | 14 | $412 | $29 |
| Furosemide | 21 | $258 | $12 |
| Levofloxacin | 27 | $247 | $9 |
2016: 17 drugs
| Esbriet | 27 | $207,332 | $7,679 |
| Spiriva Respimat | 151 | $37,600 | $249 |
| Dulera | 164 | $30,127 | $184 |
| Qvar | 53 | $5,034 | $95 |
| Mycophenolate Mofetil | 17 | $4,903 | $288 |
| Montelukast | 136 | $2,479 | $18 |
| Ethambutol | 12 | $2,132 | $178 |
| Prednisone | 55 | $1,704 | $31 |
| Rifampin | 12 | $1,350 | $112 |
| Azithromycin | 35 | $923 | $26 |
| Ventolin Hfa | 24 | $899 | $37 |
| Fluticasone Propionate | 50 | $882 | $18 |
| Ipratropium | 31 | $710 | $23 |
| Proair Hfa | 20 | $645 | $32 |
| Levofloxacin | 26 | $285 | $11 |
| Sulfamethoxazole-Trimethoprim | 18 | $277 | $15 |
| Furosemide | 11 | $208 | $19 |
2015: 21 drugs
| Esbriet | 17 | $141,159 | $8,303 |
| Letairis | 15 | $116,158 | $7,744 |
| Spiriva | 147 | $46,588 | $317 |
| Dulera | 157 | $37,895 | $241 |
| Advair Diskus | 12 | $7,606 | $634 |
| Spiriva Respimat | 18 | $4,807 | $267 |
| Qvar | 45 | $4,664 | $104 |
| Montelukast | 185 | $4,185 | $23 |
| Mycophenolate Mofetil | 12 | $4,060 | $338 |
| Ethambutol | 13 | $2,498 | $192 |
| Fluticasone Propionate | 52 | $1,379 | $27 |
| Proair Hfa | 34 | $1,057 | $31 |
| Prednisone | 32 | $1,008 | $31 |
| Rifampin | 12 | $736 | $61 |
| Azithromycin | 17 | $648 | $38 |
| Sulfamethoxazole-Trimethoprim | 17 | $331 | $19 |
| Pantoprazole | 11 | $324 | $29 |
| Furosemide | 22 | $260 | $12 |
| Ipratropium | 12 | $253 | $21 |
| Hydralazine | 13 | $192 | $15 |
| Trazodone | 11 | $102 | $9 |
2014: 19 drugs
| Letairis | 25 | $183,422 | $7,337 |
| Spiriva | 237 | $67,467 | $285 |
| Dulera | 188 | $42,967 | $229 |
| Advair Diskus | 20 | $10,538 | $527 |
| Mycophenolate Mofetil | 16 | $5,486 | $343 |
| Montelukast | 160 | $5,170 | $32 |
| Ethambutol | 17 | $3,192 | $188 |
| Qvar | 28 | $2,549 | $91 |
| Proair Hfa | 59 | $1,849 | $31 |
| Azithromycin | 31 | $1,784 | $58 |
| Fluticasone Propionate | 57 | $1,445 | $25 |
| Prednisone | 56 | $1,137 | $20 |
| Rifampin | 17 | $955 | $56 |
| Pantoprazole | 19 | $579 | $30 |
| Furosemide | 36 | $423 | $12 |
| Ipratropium | 21 | $399 | $19 |
| Amoxicillin | 21 | $346 | $16 |
| Levofloxacin | 14 | $202 | $14 |
| Sulfamethoxazole-Trimethoprim | 11 | $147 | $13 |
2013: 14 drugs
| Spiriva | 180 | $46,442 | $258 |
| Dulera | 127 | $25,100 | $198 |
| Advair Diskus | 42 | $17,373 | $414 |
| Ethambutol | 23 | $3,658 | $159 |
| Proair Hfa | 71 | $2,108 | $30 |
| Qvar | 13 | $2,024 | $156 |
| Azithromycin | 29 | $1,785 | $62 |
| Fluticasone Propionate | 58 | $1,555 | $27 |
| Rifampin | 26 | $1,339 | $51 |
| Montelukast | 24 | $851 | $35 |
| Ipratropium | 18 | $410 | $23 |
| Furosemide | 28 | $368 | $13 |
| Prednisone | 18 | $316 | $18 |
| Sulfamethoxazole-Trimethoprim | 12 | $239 | $20 |
Money from drug and device companies
$3,068 in 2025
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $3,068 | 9 payments
|
See all 9 published payments
| Intuitive Surgical | Meals · 2025-10-14 | Da Vinci Surgical System | $34 |
| Intuitive Surgical | Meals · 2025-06-24 | Da Vinci Surgical System | $6 |
| Intuitive Surgical | Meals · 2025-03-11 | Da Vinci Surgical System | $9 |
| Intuitive Surgical | Meals · 2025-03-11 | Da Vinci Surgical System | $15 |
| Intuitive Surgical | Travel · 2025-01-23 | Da Vinci Surgical System | $174 |
| Intuitive Surgical | Travel · 2025-01-16 | Da Vinci Surgical System | $19 |
| Intuitive Surgical | Travel · 2025-01-16 | Da Vinci Surgical System | $295 |
| Intuitive Surgical | Meals · 2025-01-07 | Da Vinci Surgical System | $16 |
| Intuitive Surgical | Education · 2025-01-07 | Da Vinci Surgical System | $2,500 |
Professional record
- NPI
- 1679760268
- Licence
- CA A88283California A88283: Current · expires 2028-07-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 243 Sierra Vista Ave, Mountain View, CA, 94043
- NPI first listed
- 2007-09-27
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.